Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Integrating Chemistry Data Sources Provides Big Benefits

Posted on April 17th, 2019 by in Pharma R&D

Unification across platforms is providing multiple benefits to organizations who pull together massive amounts of data across multiple platforms. Technology is evolving to eliminate data redundancy and silos as evidenced by the collaboration between Elsevier and Lundbeck.

(more…)

4P Pharma and Elsevier Life Sciences Collaborate in “the Hive” to Propel Discovery Forward

Posted on April 15th, 2019 by in The Hive

4P Pharmaceutical is an Elsevier partner and Hive participant who has leveraged solutions to further their early stage drug development process. They’ve made great strides in particular with the Elsevier.

(more…)

Data-Driven Technologies are Shaking Up the Drug Development Process

Posted on March 15th, 2019 by in Pharma R&D

For many, many years, the findings of scientific research were published in an always-growing collection of scientific journals that spun off into more and more specialized disciplines. Today’s scientists have to think far beyond scholarly journals subscriptions and wrestle instead with search strategies and informatics.

(more…)

Three ways to reduce the cost of precision medicine

Posted on March 12th, 2019 by in Pharma R&D

In December 2018, the FDA announced it has formally recognized a public database containing genomic information, a huge milestone in the evolving field of precision medicine. Now researchers can use this information to validate their tests instead of having to generate their own data.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 7